Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Breast Cancer

  Free Subscription


Articles published in BMJ

Retrieve available abstracts of 50 articles:
HTML format



Single Articles


    July 2021
  1. MAGUIRE R, McCann L, Kotronoulas G, Kearney N, et al
    Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART).
    BMJ. 2021;374:n1647.
    PubMed     Abstract available


    April 2021
  2. ABUDHAISE H, Dani M, Devalia H
    Unilateral nipple rash in a man.
    BMJ. 2021;373:n750.
    PubMed    


    March 2021

  3. Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai.
    BMJ. 2021;372:n738.
    PubMed    


    February 2021
  4. MITTRA I, Mishra GA, Dikshit RP, Gupta S, et al
    Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai.
    BMJ. 2021;372:n256.
    PubMed     Abstract available


  5. MN W, L J, Jw H, Ks R, et al
    Use of SNP chips to detect rare pathogenic variants: retrospective, population based diagnostic evaluation.
    BMJ. 2021;372:n214.
    PubMed     Abstract available


    December 2020
  6. DODWELL D, Jauhari Y, Gathani T, Cromwell D, et al
    Treatment variation in early breast cancer in the UK.
    BMJ. 2020;371:m4237.
    PubMed    


    November 2020
  7. CHIN YR, Warner R
    Diffuse bruising on left breast.
    BMJ. 2020;371:m4179.
    PubMed    


  8. KLEE G, Langan EA
    Just an odd rash?
    BMJ. 2020;371:m4032.
    PubMed    


    October 2020
  9. VINOGRADOVA Y, Coupland C, Hippisley-Cox J
    Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases.
    BMJ. 2020;371:m3873.
    PubMed     Abstract available


  10. GRIFFIN S
    Pause in breast cancer screening is opportunity to re-evaluate programme, says critic.
    BMJ. 2020;371:m3810.
    PubMed    


    September 2020
  11. THORNTON H
    Blatant disregard to proper consent continues in screening programmes.
    BMJ. 2020;370:m3592.
    PubMed    


  12. ZHANG Y, Birmann BM, Han J, Giovannucci EL, et al
    Personal use of permanent hair dyes and cancer risk and mortality in US women: prospective cohort study.
    BMJ. 2020;370:m2942.
    PubMed     Abstract available


    August 2020
  13. MAHASE E
    Trial to extend breast cancer screening won't resume randomisation after pandemic.
    BMJ. 2020;370:m3337.
    PubMed    


  14. VAIDYA JS, Bulsara M, Baum M, Wenz F, et al
    Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial.
    BMJ. 2020;370:m2836.
    PubMed     Abstract available


  15. WISE J
    Breast cancer: study claiming that screening women in their 40s saves lives "found the opposite," say critics.
    BMJ. 2020;370:m3191.
    PubMed    


    May 2020
  16. MANNU GS, Wang Z, Broggio J, Charman J, et al
    Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988-2014: population based observational cohort study.
    BMJ. 2020;369:m1570.
    PubMed     Abstract available


  17. RICHARDSON TG, Sanderson E, Elsworth B, Tilling K, et al
    Use of genetic variation to separate the effects of early and later life adiposity on disease risk: mendelian randomisation study.
    BMJ. 2020;369:m1203.
    PubMed     Abstract available


    March 2020
  18. TORJESEN I
    Health groups criticise EU funded breast cancer screening study as a "missed opportunity".
    BMJ. 2020;368:m855.
    PubMed    


    January 2020
  19. MAHASE E
    AI system outperforms radiologists in first reading of breast cancer screening, study claims.
    BMJ. 2020;368:m16.
    PubMed    


    October 2019
  20. RYMER J, Brian K, Regan L
    HRT and breast cancer risk.
    BMJ. 2019;367:l5928.
    PubMed    


    September 2019
  21. DYER C
    Asylum seeker whose breast cancer treatment was delayed over eligibility has died.
    BMJ. 2019;366:l5692.
    PubMed    


  22. MAHASE E
    Tell women about long term breast cancer risk with HRT, drug agency tells doctors.
    BMJ. 2019;366:l5350.
    PubMed    


    August 2019
  23. MAHASE E
    Breast cancer risk associated with HRT increases with longer use, finds study.
    BMJ. 2019;366:l5332.
    PubMed    


    July 2019
  24. MAHASE E
    Breast cancer: NICE approves new drug combination treatment.
    BMJ. 2019;366:l4727.
    PubMed    


  25. CHAZELAS E, Srour B, Desmetz E, Kesse-Guyot E, et al
    Sugary drink consumption and risk of cancer: results from NutriNet-Sante prospective cohort.
    BMJ. 2019;366:l2408.
    PubMed     Abstract available


    June 2019
  26. RICHMOND RC, Anderson EL, Dashti HS, Jones SE, et al
    Investigating causal relations between sleep traits and risk of breast cancer in women: mendelian randomisation study.
    BMJ. 2019;365:l2327.
    PubMed     Abstract available


  27. SCHERNHAMMER ES
    Larks, owls, and breast cancer.
    BMJ. 2019;365:l4267.
    PubMed    


    May 2019
  28. MAHASE E
    Hormone therapy increases breast cancer risk in transgender women, study finds.
    BMJ. 2019;365:l2221.
    PubMed    


  29. DE BLOK CJM, Wiepjes CM, Nota NM, van Engelen K, et al
    Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands.
    BMJ. 2019;365:l1652.
    PubMed     Abstract available


    April 2019
  30. BEWLEY S, Blennerhassett M, Payne M
    Cost of extending the NHS breast screening age range in England.
    BMJ. 2019;365:l1293.
    PubMed    


  31. CHRISTIE B
    Tayside breast cancer patients are recalled after treatment is criticised.
    BMJ. 2019;365:l1542.
    PubMed    


    October 2018
  32. MATTHEWS A, Stanway S, Farmer RE, Strongman H, et al
    Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review.
    BMJ. 2018;363:k3845.
    PubMed     Abstract available


    September 2018
  33. THORNTON H
    Yet another risk score-will it really help decision making?
    BMJ. 2018;362:k3847.
    PubMed    


    July 2018
  34. POTTER S, MacKenzie M, Blazeby JM
    Does the addition of mesh improve outcomes in implant based breast reconstruction after mastectomy for breast cancer?
    BMJ. 2018;362:k2607.
    PubMed    


    June 2018
  35. MAYOR S
    Seven in 10 women with early breast cancer do not need chemotherapy, study finds.
    BMJ. 2018;361:k2473.
    PubMed    


    May 2018
  36. BAGENAL J, Roche N, Ross G, Kirby A, et al
    Should patients with ductal carcinoma in situ be treated with adjuvant whole breast radiotherapy after breast conservation surgery?
    BMJ. 2018;361:k1410.
    PubMed    


  37. HAWKES N
    Breast cancer screening error: fatal mistake or lucky escape?
    BMJ. 2018;361:k2036.
    PubMed    


    January 2018
  38. WHITE H, Barrett M, Gooding C
    Chronic hip pain.
    BMJ. 2018;360:j5882.
    PubMed    


  39. VAIDYA JS, Massarut S, Vaidya HJ, Alexander EC, et al
    Rethinking neoadjuvant chemotherapy for breast cancer.
    BMJ. 2018;360:j5913.
    PubMed    


    December 2017
  40. MAYOR S
    Mammography screening reduces breast cancer deaths in Ireland, study finds.
    BMJ. 2017;359:j5932.
    PubMed    


  41. KALAGER M
    Breast cancer screening.
    BMJ. 2017;359:j5625.
    PubMed    


  42. AUTIER P, Boniol M, Koechlin A, Pizot C, et al
    Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study.
    BMJ. 2017;359:j5224.
    PubMed     Abstract available


    November 2017
  43. DYER C
    Woman who rejected breast cancer diagnosis may undergo surgery without her consent.
    BMJ. 2017;359:j5358.
    PubMed    


  44. IACOBUCCI G
    NICE recommends routine NHS funding for new breast cancer drugs.
    BMJ. 2017;359:j5309.
    PubMed    


  45. FEINMANN J
    Number of UK patients with metastatic breast cancer isn't known.
    BMJ. 2017;359:j5205.
    PubMed    


  46. MAYOR S
    Risk of breast cancer recurrence remains for years after endocrine treatment ends, study finds.
    BMJ. 2017;359:j5167.
    PubMed    


  47. NACHIAPPAN S, Howlett DC
    Renal transplant, previous breast cancer, and progressive breathlessness.
    BMJ. 2017;359:j4773.
    PubMed    


    October 2017
  48. DIMITRAKOPOULOU VI, Tsilidis KK, Haycock PC, Dimou NL, et al
    Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study.
    BMJ. 2017;359:j4761.
    PubMed     Abstract available


  49. ROBERTSON E
    Patient commentary: the current model has failed.
    BMJ. 2017;359:j4568.
    PubMed    


    April 2017
  50. CRAWFORD SM
    Cancer diagnostic centres must have high throughput.
    BMJ. 2017;357:j2070.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: